One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Autoimmune Disease Drug Market

[ 英語タイトル ] Autoimmune Disease Drug Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025


Product Code : IGRHC00104250
Survey : Infinium Global Research
Publish On : May, 2021
Number of Pages : 100
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4795 / Question Form
Enterprise User USD7195 / Question Form

Company Profiles
The companies covered in the report include
• F. Hoffmann-La Roche AG
• Abbott Laboratories
• Bristol-Myers Squibb Company
• Amgen Inc.
• Johnson & Johnson
• AstraZeneca plc.
• Pfizer Inc.
• Novartis AG
• Other companies

[Report Description]

The report on the global autoimmune disease drug market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global autoimmune disease drug market to grow with a CAGR of 4.3% over the forecast period from 2019-2025. The study on autoimmune disease drug market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on autoimmune disease drug market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global autoimmune disease drug market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global autoimmune disease drug market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
• Increasing population of autoimmune disease
• Initiatives taken by the government and private sector for spreading awareness regarding autoimmune disease
2) Restraints
• Late or troublesome diagnosis owing to a lack of understanding of autoimmune diseases
3) Opportunities
• Substantial rise in biopharmaceutical research companies as well as raising funds for the advancement of technologies

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global autoimmune disease drug market is segmented on the basis of indication, drug class, and distribution channel.

The Global Autoimmune Disease Drug Market by Indication
• Diabetes Mellitus Type 1
• Rheumatic Diseases
• Multiple Sclerosis
• Rare Diseases
• Other Indication

The Global Autoimmune Disease Drug Market by Drug Class
• NSAIDs
• Anti-inflammatory
• Interferons
• Antihyperglycemic
• Immunosuppressants
• Other Drug Class

The Global Autoimmune Disease Drug Market by Distribution Channel
• Hospital Pharmacies
• Online Stores
• Retail Pharmacies


Company Profiles
The companies covered in the report include
• F. Hoffmann-La Roche AG
• Abbott Laboratories
• Bristol-Myers Squibb Company
• Amgen Inc.
• Johnson & Johnson
• AstraZeneca plc.
• Pfizer Inc.
• Novartis AG
• Other companies

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the autoimmune disease drug market.
2. Complete coverage of all the segments in the autoimmune disease drug market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global autoimmune disease drug market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Content

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Autoimmune Disease Drug Market Highlights
2.2. Autoimmune Disease Drug Market Projection
2.3. Autoimmune Disease Drug Market Regional Highlights

3. Global Autoimmune Disease Drug Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Indication
3.4.2. IGR-Growth Matrix Analysis by Drug Class
3.4.3. IGR-Growth Matrix Analysis by Distribution Channel
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Autoimmune Disease Drug Market

4. Autoimmune Disease Drug Market Macro Indicator Analysis

5. Global Autoimmune Disease Drug Market by Indication
5.1. Diabetes Mellitus Type 1
5.2. Rheumatic Diseases
5.3. Multiple Sclerosis
5.4. Rare Diseases
5.5. Other Indication

6. Global Autoimmune Disease Drug Market by Drug Class
6.1. NSAIDs
6.2. Anti-inflammatory
6.3. Interferons
6.4. Antihyperglycemic
6.5. Immunosuppressants
6.6. Other Drug Class

7. Global Autoimmune Disease Drug Market by Distribution Channel
7.1. Hospital Pharmacies
7.2. Online Stores
7.3. Retail Pharmacies

8. Global Autoimmune Disease Drug Market by Region 2019-2025
8.1. North America
8.1.1. North America Autoimmune Disease Drug Market by Indication
8.1.2. North America Autoimmune Disease Drug Market by Drug Class
8.1.3. North America Autoimmune Disease Drug Market by Distribution Channel
8.1.4. North America Autoimmune Disease Drug Market by Country
8.2. Europe
8.2.1. Europe Autoimmune Disease Drug Market by Indication
8.2.2. Europe Autoimmune Disease Drug Market by Drug Class
8.2.3. Europe Autoimmune Disease Drug Market by Distribution Channel
8.2.4. Europe Autoimmune Disease Drug Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Autoimmune Disease Drug Market by Indication
8.3.2. Asia-Pacific Autoimmune Disease Drug Market by Drug Class
8.3.3. Asia-Pacific Autoimmune Disease Drug Market by Distribution Channel
8.3.4. Asia-Pacific Autoimmune Disease Drug Market by Country
8.4. RoW
8.4.1. RoW Autoimmune Disease Drug Market by Indication
8.4.2. RoW Autoimmune Disease Drug Market by Drug Class
8.4.3. RoW Autoimmune Disease Drug Market by Distribution Channel
8.4.4. RoW Autoimmune Disease Drug Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Autoimmune Disease Drug Market
9.2. Companies Profiles
9.2.1. F. Hoffmann-La Roche AG
9.2.2. Abbott Laboratories
9.2.3. Bristol-Myers Squibb Company
9.2.4. Amgen Inc.
9.2.5. Johnson & Johnson
9.2.6. AstraZeneca plc.
9.2.7. Pfizer Inc.
9.2.8. Novartis AG
9.2.9. Other companies

10. Appendix
10.1. Primary Research Findings and Questionnaire

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+